» Articles » PMID: 39340118

Correction: Mukherjee Et Al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. 2023, , 510

Abstract

The authors would like to make the following corrections to this published paper [...].

Citing Articles

Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. 2023, , 510.

Mukherjee A, Wanjari U, Gopalakrishnan A, Kannampuzha S, Murali R, Namachivayam A Vaccines (Basel). 2024; 12(9).

PMID: 39340118 PMC: 11435671. DOI: 10.3390/vaccines12090996.


A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals.

Domingo J Arch Toxicol. 2024; 98(11):3603-3617.

PMID: 39225797 PMC: 11489230. DOI: 10.1007/s00204-024-03854-8.

References
1.
Piscoya A, Ng-Sueng L, Parra Del Riego A, Cerna-Viacava R, Pasupuleti V, Roman Y . Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. PLoS One. 2020; 15(12):e0243705. PMC: 7728272. DOI: 10.1371/journal.pone.0243705. View

2.
Guo J, Sheng K, Wu S, Chen H, Xu W . An Update on the Relationship of SARS-CoV-2 and Male Reproduction. Front Endocrinol (Lausanne). 2021; 12:788321. PMC: 8649688. DOI: 10.3389/fendo.2021.788321. View

3.
Mukherjee A, Wanjari U, Gopalakrishnan A, Kannampuzha S, Murali R, Namachivayam A . Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. 2023, , 510. Vaccines (Basel). 2024; 12(9). PMC: 11435671. DOI: 10.3390/vaccines12090996. View